Fight against cancer gets help from salmonella bacteria

Oct 25, 2010

Scientists have uncovered a novel mechanism by which Salmonella bacteria infect humans and say the discovery could potentially be exploited to kill cancerous cells.

In an article published in the journal Science, researchers from the University of Glasgow and the University of Massachusetts Medical School, describe how uses caspase-3, an enzyme produced by the infected host cell, to deliberately increase at the site of infection.

Normally, caspase-3 plays an important role in the body by removing damaged or malfunctioning cells from the system through a process known as ‘Programmed ’. It is this process of cell death that is often defective in cancer cells.

The researchers, Dr. Dónal Wall from the University of Glasgow and Dr. Srikanth Chittur and Professor Beth McCormick from the University of Massachusetts Medical School, demonstrate that the Salmonella bacterial SipA is responsible for inducing caspase-3 activation within the host cell.

Dr. Wall, a lecturer in microbiology in the Institute of Infection, Immunity & Inflammation, said: “The novelty of this research is that we show how the are undermining the host cell and getting it to process the bacterial toxins into smaller functional units.

“The bacteria deliver large toxins into the cell and then use the host enzyme, caspase-3, to divide these proteins. These toxins can then go to different parts of the cell to carry out their individual functions.

“It is very efficient: the bacteria deliver one toxin and, with the inadvertent help of the host, this one toxin can become many when inside the cell.”

Caspase-3 only cuts specific sequences within proteins known as caspase-3 cleavage sites. Notably, caspase-3 cleavage sites are found in several Salmonella proteins, however these appear to be restricted to proteins that play a role in bacterial entry or proteins that are used to overpower the , indicating this may be a general strategy employed by the bacteria to aid with processing bacterial toxins.

Dr Wall added: “Although this work is important for the field of host-pathogen interactions it also highlights a process that could be exploited in cancer therapeutics to activate Programmed Cell Death in cells in which the early stages of this process are defective.”

Altered and attenuated forms of Salmonella have already been used by other scientists to target certain types of cancer cells in the lab but this latest research, supported by research funding body Tenovus Scotland, has the potential to make such treatments more effective.

Explore further: Revealing camouflaged bacteria

More information: The paper Salmonella Pathogenesis and Processing of Secreted Effectors by Caspase-3 is available online at Science.

Provided by University of Glasgow

5 /5 (2 votes)

Related Stories

Protein that promotes cancer cell growth identified

Jul 24, 2009

Scientists at Burnham Institute for Medical Research (Burnham) have found that the Caspase-8 protein, long known to play a major role in promoting programmed cell death (apoptosis), helps relay signals that can cause cancer ...

Recommended for you

Revealing camouflaged bacteria

6 minutes ago

A research team at the Biozentrum of the University of Basel has discovered an protein family that plays a central role in the fight against the bacterial pathogen Salmonella within the cells. The so cal ...

Lifestyle determines gut microbes

23 hours ago

An international team of researchers has for the first time deciphered the intestinal bacteria of present-day hunter-gatherers.

Rethink education to fuel bioeconomy, says report

Apr 15, 2014

Microbes can be highly efficient, versatile and sophisticated manufacturing tools, and have the potential to form the basis of a vibrant economic sector. In order to take full advantage of the opportunity microbial-based ...

User comments : 0

More news stories

EU must take urgent action on invasive species

The EU must take urgent action to halt the spread of invasive species that are threatening native plants and animals across Europe, according to a scientist from Queen's University Belfast.

HIV+ women respond well to HPV vaccine

HIV-positive women respond well to a vaccine against the human papillomavirus (HPV), even when their immune system is struggling, according to newly published results of an international clinical trial. The study's findings ...